Femasys Inc. (FEMY)
USD 1.12
(-2.61%)
USD 1.12
(-2.61%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 27.75 Million USD | 64.28% |
| 2022 | 16.89 Million USD | -40.88% |
| 2021 | 28.57 Million USD | 275.7% |
| 2020 | 7.6 Million USD | -39.85% |
| 2019 | 12.64 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 20.27 Million USD | -16.8% |
| 2024 Q1 | 24.37 Million USD | -12.2% |
| 2023 FY | 27.75 Million USD | 64.28% |
| 2023 Q2 | 14.31 Million USD | 3.22% |
| 2023 Q1 | 13.86 Million USD | -17.92% |
| 2023 Q4 | 27.75 Million USD | 86.86% |
| 2023 Q3 | 14.85 Million USD | 3.77% |
| 2022 Q4 | 16.89 Million USD | -15.66% |
| 2022 Q2 | 23.12 Million USD | -9.45% |
| 2022 Q1 | 25.53 Million USD | -10.65% |
| 2022 FY | 16.89 Million USD | -40.88% |
| 2022 Q3 | 20.03 Million USD | -13.36% |
| 2021 Q1 | 6.68 Million USD | -12.1% |
| 2021 FY | 28.57 Million USD | 275.7% |
| 2021 Q4 | 28.57 Million USD | -8.3% |
| 2021 Q3 | 31.16 Million USD | -8.31% |
| 2021 Q2 | 33.98 Million USD | 408.32% |
| 2020 Q1 | - USD | 0.0% |
| 2020 Q4 | 7.6 Million USD | 0.0% |
| 2020 FY | 7.6 Million USD | -39.85% |
| 2019 FY | 12.64 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 180.36 Million USD | 84.612% |
| AngioDynamics, Inc. | 317.67 Million USD | 91.263% |
| AtriCure, Inc. | 613.93 Million USD | 95.479% |
| Avinger, Inc. | 13.77 Million USD | -101.567% |
| Azenta, Inc. | 2.88 Billion USD | 99.038% |
| BioLife Solutions, Inc. | 412.71 Million USD | 93.275% |
| The Cooper Companies, Inc. | 11.65 Billion USD | 99.762% |
| Daxor Corporation | 34.86 Million USD | 20.4% |
| Ekso Bionics Holdings, Inc. | 28.91 Million USD | 4.019% |
| GlucoTrack, Inc. | 4.9 Million USD | -465.868% |
| Harvard Bioscience, Inc. | 137.36 Million USD | 79.794% |
| Hologic, Inc. | 9.15 Billion USD | 99.697% |
| ICU Medical, Inc. | 4.37 Billion USD | 99.366% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 99.82% |
| KORU Medical Systems, Inc. | 28.46 Million USD | 2.478% |
| LeMaitre Vascular, Inc. | 346.77 Million USD | 91.996% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -346.324% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -346.324% |
| Masimo Corporation | 3.04 Billion USD | 99.087% |
| Microbot Medical Inc. | 8.32 Million USD | -233.323% |
| Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | 83.855% |
| Merit Medical Systems, Inc. | 2.32 Billion USD | 98.806% |
| Nephros, Inc. | 11.86 Million USD | -134.009% |
| NovoCure Limited | 1.14 Billion USD | 97.578% |
| NEXGEL, Inc. | 9.95 Million USD | -178.813% |
| NEXGEL, Inc. | 9.95 Million USD | -178.813% |
| Singular Genomics Systems, Inc. | 265.46 Million USD | 89.545% |
| OraSure Technologies, Inc. | 482.84 Million USD | 94.252% |
| Pro-Dex, Inc. | 54.21 Million USD | 48.799% |
| Pulse Biosciences, Inc. | 60.8 Million USD | 54.352% |
| Predictive Oncology Inc. | 14.41 Million USD | -92.518% |
| Precision Optics Corporation, Inc. | 16.91 Million USD | -64.114% |
| QuidelOrtho Corporation | 8.56 Billion USD | 99.676% |
| Repligen Corporation | 2.82 Billion USD | 99.017% |
| Sanara MedTech Inc. | 73.87 Million USD | 62.427% |
| STAAR Surgical Company | 488.69 Million USD | 94.32% |
| Sharps Technology, Inc. | 11.78 Million USD | -135.433% |
| Utah Medical Products, Inc. | 135.45 Million USD | 79.51% |
| DENTSPLY SIRONA Inc. | 7.37 Billion USD | 99.623% |
| Jin Medical International Ltd. | 32.9 Million USD | 15.645% |